PRELUDE THERAPEUTICS INC (PRLD) Return on equity 2024–2025
PRELUDE THERAPEUTICS INC (PRLD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-145.0%FY2025 · since FY2024: -96.7% → -145.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -145.0% | -48.2 pp |
| FY2024 | -96.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PRLD financial trends
PRLD RevenuePRLD Net incomePRLD Net marginPRLD Gross profitPRLD Gross marginPRLD Operating incomePRLD Operating marginPRLD Operating cash flowPRLD Free cash flowPRLD Capital expendituresPRLD Stock buybacksPRLD Dividends paidPRLD Total assetsPRLD Total liabilitiesPRLD Shareholders’ equityPRLD overview →